Lindsay Pineau

Strategies to Increase Diversity in Rare Genetic Disease Clinical Trials

By Rebecca Sutphen, MD, FACMGG, Co-Founder and Chief Medical Officer, InformedDNA, and Karmen Trzupek, MS, Board-Certified Genetic Counselor Diversity in all clinical research—including rare disease research—is currently under scrutiny, partly because of disparities experienced with COVID-19. Rightly so, as data show that 86% of genomics studies to date have involved people of European ancestry, which …

Strategies to Increase Diversity in Rare Genetic Disease Clinical Trials Read More »

Achieving Value through Comprehensive Genomic Benefits Management (GBM)

Executive Summary, by InformedDNA Precision medicine that harnesses advances in genomics holds enormous promise for impacting every aspect of a health plan’s business. When properly integrated, genomics enables more tailored care with the potential for tremendously improved outcomes–especially in specialties such as oncology and reproductive health. Genomics is a technically complex discipline with a growing …

Achieving Value through Comprehensive Genomic Benefits Management (GBM) Read More »

Solverwp- WordPress Theme and Plugin